Skip to main content
Top
Published in: Diseases of the Colon & Rectum 3/2004

01-03-2004 | Original Contribution

A High Degree of Aneuploidy, Loss of p53 Gene, and Low Soluble p53 Protein Serum Levels Are Detected in Ulcerative Colitis Patients

Authors: Maya Rosman-Urbach, Ph.D., Yaron Niv, M.D., Yehudith Birk, Ph.D., Patricia Smirnoff, Ph.D., Igor Zusman, Ph.D., Sara Morgenstern, M.D., Betty Schwartz, Ph.D.

Published in: Diseases of the Colon & Rectum | Issue 3/2004

Login to get access

PURPOSE

The causes for the increased risk of colorectal cancer associated with ulcerative colitis have not been fully defined. Colonic tissue of ulcerative colitis patients was examined for changes in chromosome-17-centromere copy number, loss of the p53 gene, and alterations in serum levels of the 53-kDa protein. This study was performed under the assumption that these molecular events correlate with ulcerative colitis status and duration.

METHODS

Ulcerative colitis patients (n = 42) and healthy controls (n = 37) participated in the study. All participants were histopathologically and medically diagnosed. The stage of ulcerative colitis patients was stratified according to increasing risk factors for the development of colorectal cancer: left-sided colitis, pancolitis, sclerosing cholangitis, and dysplasia-associated lesions or masses. Changes in centromere number of chromosome 17 alone or in association with changes in copy number of the p53 gene were analyzed in colon tissue biopsies by fluorescence in situ hybridization. Serum p53 level was determined in blood samples by immunoprecipitation followed by separation using high-pressure liquid chromatography.

RESULTS

Changes in chromosome 17 and p53 copy number and lower levels of serum p53 protein in ulcerative colitis patients directly correlated with colorectal cancer risk factors. All values significantly differed from controls. Significant direct correlations were obtained for ulcerative colitis disease duration, levels of p53 in the serum, and extent of aneuploidy.

CONCLUSIONS

We demonstrate that in the colonic mucosa of ulcerative colitis patients, high levels of genomic instability, changes in p53 gene copy number, and lower levels of p53 in the serum directly correlate with the extent of disease duration and increased risk factors for colorectal cancer. Any of the measurements described herein can provide an acceptable prognostic tool in the assessment of colorectal cancer risk in ulcerative colitis patients.
Literature
1.
go back to reference Fergus, S 1993Pathogenesis of ulcerative colitisLancet34240712 Fergus, S 1993Pathogenesis of ulcerative colitisLancet34240712
2.
go back to reference Hugot, JP, Zouali, H, Lesage, S, Thomas, G 1999Etiology of the inflammatory bowel diseasesInt J Colorectal Dis1429 Hugot, JP, Zouali, H, Lesage, S, Thomas, G 1999Etiology of the inflammatory bowel diseasesInt J Colorectal Dis1429
3.
go back to reference Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991;325:928–37, 1008-16. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991;325:928–37, 1008-16.
4.
go back to reference Eaden, JA, Abrams, KR, Mayberry, JF 2001The risk of colorectal cancer in ulcerative colitisGut4852635 Eaden, JA, Abrams, KR, Mayberry, JF 2001The risk of colorectal cancer in ulcerative colitisGut4852635
5.
go back to reference Ekbom, A, Helmick, C, Zack, M, Adami, HO 1990Ulcerative colitis and colorectal cancer: a population based studyN Engl J Med323122833 Ekbom, A, Helmick, C, Zack, M, Adami, HO 1990Ulcerative colitis and colorectal cancer: a population based studyN Engl J Med323122833
6.
go back to reference Markowitz, J, McKinley, M, Kahn, E, et al. 1997Endoscopic screening for dysplasia and muscosal aneuploidy in adolescents and young adults with childhood onset colitisAm J Gastroenterol9220016 Markowitz, J, McKinley, M, Kahn, E,  et al. 1997Endoscopic screening for dysplasia and muscosal aneuploidy in adolescents and young adults with childhood onset colitisAm J Gastroenterol9220016
7.
go back to reference Ahnen, DJ 1992Abnormal DNA content as a biomarker of large bowel cancer risk and prognosisJ Cell Biochem Suppl16614350 Ahnen, DJ 1992Abnormal DNA content as a biomarker of large bowel cancer risk and prognosisJ Cell Biochem Suppl16614350
8.
go back to reference Befrits, R, Hammarberg, C, Rubio, C, Jaramillo, E, Tribukait, B 1994DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis: a 10-year follow-up studyDis Colon Rectum3731320 Befrits, R, Hammarberg, C, Rubio, C, Jaramillo, E, Tribukait, B 1994DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis: a 10-year follow-up studyDis Colon Rectum3731320
9.
go back to reference Lindberg, JO, Stenlling, RB, Rutegard, JN 1999DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitisBr J Surg8694750 Lindberg, JO, Stenlling, RB, Rutegard, JN 1999DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitisBr J Surg8694750
10.
go back to reference Porschen, R, Robin, U, Schumacher, A, et al. 1992DNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric studyGut336637 Porschen, R, Robin, U, Schumacher, A,  et al. 1992DNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric studyGut336637
11.
go back to reference Wang, TH, Wang, HS 1996P53, apoptosis and human cancersJ Formos Med Assoc9550922 Wang, TH, Wang, HS 1996P53, apoptosis and human cancersJ Formos Med Assoc9550922
12.
go back to reference Kim, HJ, Chang, SK 1998P53 mutation in patients with ulcerative colitis in rectal biopsyKorean J Intern Med131106 Kim, HJ, Chang, SK 1998P53 mutation in patients with ulcerative colitis in rectal biopsyKorean J Intern Med131106
13.
go back to reference Brentnall, TA, Crispin, DA, Rabinovitch, PS, et al. 1994Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitisGastroenterology10736978 Brentnall, TA, Crispin, DA, Rabinovitch, PS,  et al. 1994Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitisGastroenterology10736978
14.
go back to reference Morson, BC 1995Precancer and cancer in inflammatory bowel diseasePathology (Phila)1717380 Morson, BC 1995Precancer and cancer in inflammatory bowel diseasePathology (Phila)1717380
15.
go back to reference Powell-Tuck, J, Brown, RL, Lennard-Jones, JE 1978A comparison of oral prednisolone given as a single or multiple daily doses for active proctocolitisScand J Gastroenterol138337 Powell-Tuck, J, Brown, RL, Lennard-Jones, JE 1978A comparison of oral prednisolone given as a single or multiple daily doses for active proctocolitisScand J Gastroenterol138337
16.
go back to reference Riddell, RH, Goldman, H, Ransohoff, DF, et al. 1983Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applicationsHum Pathol1493168 Riddell, RH, Goldman, H, Ransohoff, DF,  et al. 1983Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applicationsHum Pathol1493168
17.
go back to reference Dhingra, K, Sneige, N, Pandita, TK, et al. 1994Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sectionsCytometry1610012 Dhingra, K, Sneige, N, Pandita, TK,  et al. 1994Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sectionsCytometry1610012
18.
go back to reference Zusman, I, Reifen, R, Livni, O, et al. 1997Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatusAnticancer Res17210514 Zusman, I, Reifen, R, Livni, O,  et al. 1997Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatusAnticancer Res17210514
19.
go back to reference Zusman, I, Sandler, B, Gurevich, P, et al. 1996Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detectionHum Antibod Hybridomas71238 Zusman, I, Sandler, B, Gurevich, P,  et al. 1996Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detectionHum Antibod Hybridomas71238
20.
go back to reference Ben-Hur, H, Berman, B, Sandler, B, et al. 1997Serological and immunohistochemical determinations of p53 protein in diagnosis of endometrial cancer: a comparative studyEur J Gynaecol Oncol184006 Ben-Hur, H, Berman, B, Sandler, B,  et al. 1997Serological and immunohistochemical determinations of p53 protein in diagnosis of endometrial cancer: a comparative studyEur J Gynaecol Oncol184006
21.
go back to reference Landis, JR, Koch, GG 1977The measurement of observer agreement for categorical dataBiometrics3315974 Landis, JR, Koch, GG 1977The measurement of observer agreement for categorical dataBiometrics3315974
22.
go back to reference Geboes, K, Rutgeerts, P 1999Dysplasia in inflammatory bowel diseases: definition and clinical impactCan J Gastroenterol136718 Geboes, K, Rutgeerts, P 1999Dysplasia in inflammatory bowel diseases: definition and clinical impactCan J Gastroenterol136718
23.
go back to reference Aust, DE, Willenbucher, RF, Terdiman, JP, et al. 2000Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridizationHum Pathol3110914 Aust, DE, Willenbucher, RF, Terdiman, JP,  et al. 2000Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridizationHum Pathol3110914
24.
go back to reference Thompson-Fawcett, MW, Rust, NA, Warren, BF, Mortensen, NJ 2000Aneuploidy and columnar cuff surveillance after stapled ileal pouch–anal anastomosis in ulcerative colitisDis Colon Rectum4340813 Thompson-Fawcett, MW, Rust, NA, Warren, BF, Mortensen, NJ 2000Aneuploidy and columnar cuff surveillance after stapled ileal pouch–anal anastomosis in ulcerative colitisDis Colon Rectum4340813
25.
go back to reference Willenbucher, RF, Aust, DE, Chang, CG, et al. 1999Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasiaAm J Pathol154182530 Willenbucher, RF, Aust, DE, Chang, CG,  et al. 1999Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasiaAm J Pathol154182530
26.
go back to reference Hussain, SP, Amstad, P, Raja, K, et al. 2000Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory diseaseCancer Res6033337 Hussain, SP, Amstad, P, Raja, K,  et al. 2000Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory diseaseCancer Res6033337
27.
go back to reference Lindberg, JO, Stenling, RB, Rutegard, JN 1999DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitisBr J Surg8694750 Lindberg, JO, Stenling, RB, Rutegard, JN 1999DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitisBr J Surg8694750
28.
go back to reference Greenwald, BD, Harpaz, N, Yin, J, et al. 1992Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitisCancer Res527415 Greenwald, BD, Harpaz, N, Yin, J,  et al. 1992Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitisCancer Res527415
29.
go back to reference Rabinovitch, PS, Dziadon, S, Brentnall, TA, et al. 1999Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitisCancer Res59514853 Rabinovitch, PS, Dziadon, S, Brentnall, TA,  et al. 1999Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitisCancer Res59514853
30.
go back to reference Fogt, F, Zhuang, Z, Poremba, C, et al. 1998Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis–associated dysplasia and carcinomaOncol Rep247780 Fogt, F, Zhuang, Z, Poremba, C,  et al. 1998Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis–associated dysplasia and carcinomaOncol Rep247780
31.
go back to reference Voravud, N, Shin, DM, Ro, JY, Lee, JS, Hong, WK, Hittelman, WN 1993Increased polysomies of chromosome 7 and 17 during head and neck multistage tumorigenesisCancer Res53287483 Voravud, N, Shin, DM, Ro, JY, Lee, JS, Hong, WK, Hittelman, WN 1993Increased polysomies of chromosome 7 and 17 during head and neck multistage tumorigenesisCancer Res53287483
32.
go back to reference Bulten, J, Poddighe, PJ, Robben, JC, Gemmink, JH, Wilde, PC, Hanselaar, AG 1998Interphase cytogenetic analysis of cervical intraepithelial neoplasiaAm J Pathol152495503 Bulten, J, Poddighe, PJ, Robben, JC, Gemmink, JH, Wilde, PC, Hanselaar, AG 1998Interphase cytogenetic analysis of cervical intraepithelial neoplasiaAm J Pathol152495503
33.
go back to reference Pascal, RP 1994Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomasHum Pathol25116071 Pascal, RP 1994Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomasHum Pathol25116071
34.
go back to reference Lashner, BA, Kane, SV, Hanauer, SB 1990Colon cancer surveillance in the chronic ulcerative colitis: historical cohort studyAm J Gastroenterol8510837 Lashner, BA, Kane, SV, Hanauer, SB 1990Colon cancer surveillance in the chronic ulcerative colitis: historical cohort studyAm J Gastroenterol8510837
35.
go back to reference Taylor, HW, Boyle, M, Smith, SC, Bustin, S, Williams, NS 1993Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitisBr J Surg804424 Taylor, HW, Boyle, M, Smith, SC, Bustin, S, Williams, NS 1993Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitisBr J Surg804424
36.
go back to reference Kim, HJ, Chang, SK 1998P53 mutation in patients with ulcerative colitis in rectal biopsyKorean J Intern Med131106 Kim, HJ, Chang, SK 1998P53 mutation in patients with ulcerative colitis in rectal biopsyKorean J Intern Med131106
37.
go back to reference Porschen, R, Robin, U, Schumacher, A, et al. 1992DNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric studyGut336637 Porschen, R, Robin, U, Schumacher, A,  et al. 1992DNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric studyGut336637
38.
go back to reference Klump, B, Holzmann, K, Kuhn, A, et al. 1997Distribution of cell populations with DNA aneuploidy and p53 protein expression in ulcerative colitisEur J Gastroenterol Hepatol978994 Klump, B, Holzmann, K, Kuhn, A,  et al. 1997Distribution of cell populations with DNA aneuploidy and p53 protein expression in ulcerative colitisEur J Gastroenterol Hepatol978994
39.
go back to reference Burmer, GC, Rabinovitch, PS, Haggitt, RC, et al. 1992Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 alleleGastroenterology103160210 Burmer, GC, Rabinovitch, PS, Haggitt, RC,  et al. 1992Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 alleleGastroenterology103160210
40.
go back to reference Fricke, H, Urban, S, Noehl, N, Folwaczny, C 1998Serum p53 antibodies in patients with chronic inflammatory bowel diseaseGut42899901 Fricke, H, Urban, S, Noehl, N, Folwaczny, C 1998Serum p53 antibodies in patients with chronic inflammatory bowel diseaseGut42899901
41.
go back to reference Winter, SF, Minna, JD, Johnson, BE, Takahashi, T, Gazdar, AF, Carbone, DP 1992Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutationCancer Res52416875 Winter, SF, Minna, JD, Johnson, BE, Takahashi, T, Gazdar, AF, Carbone, DP 1992Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutationCancer Res52416875
42.
go back to reference Angelopoulou, K, Diamandis, EP, Sutherland, DJ, Kellen, JA, Bunting, PS 1994Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancersInt J Cancer584807 Angelopoulou, K, Diamandis, EP, Sutherland, DJ, Kellen, JA, Bunting, PS 1994Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancersInt J Cancer584807
43.
go back to reference Schlichtholz, B, Legros, Y, Gillet, D, et al. 1992The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spotCancer Res5263804 Schlichtholz, B, Legros, Y, Gillet, D,  et al. 1992The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spotCancer Res5263804
44.
go back to reference Brevern, MC, Hollstein, MC, Cawley, HM, et al. 1996Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumorsCancer Res56491721 Brevern, MC, Hollstein, MC, Cawley, HM,  et al. 1996Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumorsCancer Res56491721
45.
go back to reference Coomber, D, Hawkins, NJ, Clark, M, Meagher, A, Ward, RL 1996Characterization and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancerJ Cancer Res Clin Oncol12275762 Coomber, D, Hawkins, NJ, Clark, M, Meagher, A, Ward, RL 1996Characterization and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancerJ Cancer Res Clin Oncol12275762
46.
go back to reference Lubin, R, Zalcman, G, Bouchet, L, et al. 1995Serum p53 antibodies as early markers of lung cancerNature Med17012 Lubin, R, Zalcman, G, Bouchet, L,  et al. 1995Serum p53 antibodies as early markers of lung cancerNature Med17012
47.
go back to reference Rossner, P,Jr, Binkova, B, Sram, RJ 2003The influence of occupational exposure to PAHs on the blood plasma levels of p53 and p21WAF1 proteinsMutat Res5358794 Rossner, P,Jr, Binkova, B, Sram, RJ 2003The influence of occupational exposure to PAHs on the blood plasma levels of p53 and p21WAF1 proteinsMutat Res5358794
48.
go back to reference Krajewska, B, Lutz, W, Pilacik, B 1998Determination of blood serum oncoprotein NEU and antioncoprotein p53––molecular biomarkers in various types of occupational exposureInt J Occup Med Environ Health113438 Krajewska, B, Lutz, W, Pilacik, B 1998Determination of blood serum oncoprotein NEU and antioncoprotein p53––molecular biomarkers in various types of occupational exposureInt J Occup Med Environ Health113438
Metadata
Title
A High Degree of Aneuploidy, Loss of p53 Gene, and Low Soluble p53 Protein Serum Levels Are Detected in Ulcerative Colitis Patients
Authors
Maya Rosman-Urbach, Ph.D.
Yaron Niv, M.D.
Yehudith Birk, Ph.D.
Patricia Smirnoff, Ph.D.
Igor Zusman, Ph.D.
Sara Morgenstern, M.D.
Betty Schwartz, Ph.D.
Publication date
01-03-2004
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 3/2004
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-003-0048-z

Other articles of this Issue 3/2004

Diseases of the Colon & Rectum 3/2004 Go to the issue